TaiGen Biotech Licenses Antibiotic To R-Pharm For Russia Region
This article was originally published in PharmAsia News
Executive Summary
TaiGen Biotechnology said it has licensed its Taigexyn (nemonoxacin) antibiotic to Russia's R-Pharm to develop and market in Turkey and former Soviet Union nations.